The monoclonal antibody, palivizumab is licensed for use in high-risk infants to prevent severe illness caused by respiratory syncytial virus (RSV). The level of its use and compliance with current jurisdictional guidelines which were amended in 2010, is unknown. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2020
• October 2020

Contact Us ORIGINS Sub-Projects Get in touch with the Research & Translation Team  Phone (08) 6375 6300 As well as ORIGINS long-term core research, ...

• The ORIGINS Project
• For collaborators
• For researchers

The Rio Tinto Children’s Diabetes Centre; a JDRF Global Centre of Excellence announces inaugural funding for researchers dedicated to type 1 diabetes. ...

• Rio Tinto Children's Diabetes Centre
• News and events

As the prevalence of allergic disease dramatically rises worldwide, prevention strategies are increasingly being considered. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2017
• March 2017

What would you discover to help a child? At Telethon Kids, our researchers are committed to Autism research that makes a real difference. ...

• 1. Telethon Kids Institute
• Campaigns
• 2017
• Discover Series

Engaging the community in COVID-19 rapid research In March 2020 the Community Engagement Team were contacted by: Researchers wanting to access ‘ ...

• 1. Telethon Kids Institute
• Our research
• Research Topics
• COVID-19
• COVID-19 Research

To assess the relative effectiveness of topical versus systemic antibiotics for people with chronic suppurative otitis media ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2018
• June 2018

MECP2 duplication syndrome (MDS) is a rare, X-linked, neurodevelopmental disorder caused by a duplication of the methyl-CpG-binding protein 2 (MECP2) gene-a gene in which loss-of-function mutations lead to Rett syndrome (RTT). MDS has an estimated live birth prevalence in males of 1/150,000. ...

• 1. Telethon Kids Institute
• Our research
• Reports and Findings
• 2022
• March 2022

Dr Rishi Kotecha knows too well the devastation of a leukaemia diagnosis in a child, treating children as a consultant at Princess Margaret Hospital. ...

• 1. Telethon Kids Institute
• News & Events
• News & Events at Telethon Kids
• 2017
• July

Tom Snelling T BMBS DTMH GDipClinEpid PhD FRACP Head, Infectious Disease Implementation Research 08 6319 1817 tom.snelling@telethonkids.org.au Head, ...

• 1. Telethon Kids Institute
• Projects